INTRODUCTION {#sec1-1}
============

To ensure successful pain relief, in-depth knowledge of local anesthetic solutions and appropriate application of local anesthetic techniques is mandatory. The inferior alveolar nerve block is the most frequently used nerve block technique for anesthetizing mandibular teeth during endodontic procedures. In case of symptomatic irreversible pulpitis, the inferior alveolar nerve block does not always result in successful pulpal anesthesia.\[[@ref1]\] The success rate of mandibular anesthesia with the inferior alveolar nerve block has been reported to vary from 38-85%.\[[@ref2][@ref3][@ref4]\] Previous studies have shown success rates of only 19-56% for inferior alveolar nerve blocks in patients with irreversible pulpitis.\[[@ref5][@ref6][@ref7][@ref8]\] It is evident from these studies that severely painful inflamed tooth is often difficult to manage conventionally and local anesthetic failure is a common occurrence.

Supplemental techniques prove handy when regional nerve blocks fail to provide adequate anesthesia. These include periodontal ligament injection, intrapulpal injection, intraosseous injection, and intraseptal injection.\[[@ref9]\] Supplemental injections are essential in patients with irreversible pulpitis as the local anesthetic injections had an eight-fold higher failure rate compared to normal patients.\[[@ref8]\] Direct pulp injections can be delivered using pressure anesthesia. Needleless device uses pressure to force the anesthetic solution safely into oral tissues. In needleless jet injection, the anesthetic solution is immediately taken up by the myelin sheath of the nerve with an onset of action of approximately 1 ms.\[[@ref10]\]

The X-tip intraosseous injection allows deposition of a local anesthetic solution directly into the cancellous bone adjacent to the tooth to be anesthetized. Success of these supplemental intraosseous injections in achieving pulpal anesthesia in patients with irreversible pulpitis has been reported to be 82-98%.\[[@ref8][@ref11]\]

The intraosseous systems available commercially in the market include the Stabident system (Fairfax Dental Inc., Miami), X-tip system (X-tip Technologies, Dentsply, Maillefer), IntraFlow (Intra Vantage, Plymouth, MN), and the Quicksleeper (DHT, Cholet, France). Clinical trial studies have been published using Stabident\[[@ref12]\], X-tip sytem\[[@ref9]\], Intra flow\[[@ref11]\], and the Quicksleeper\[[@ref13]\] system.

The X-tip anesthesia delivery system consists of a special hollow needle that serves as the drill and guide-sleeve component. The drill leads the guide sleeve through the cortical plate after which it is separated and withdrawn. The guide sleeve remains embedded in the bone and the anesthetic solution is delivered with the aid of a 27-gauge needle. The guide sleeve is removed using a hemostat once the intraosseous injection is complete.

There has been a continual search for safer and more profound local anesthetic compounds for attaining adequate pulpal anesthesia. Articaine, classified as an amide anesthetic, has increased liposolubility and potency because of the presence of a thiophene ring. Greater diffusion of articaine anesthetic solution to the teeth\[[@ref14]\] can be attributed to increased liposolubility and smaller size of thiophene ring of articaine in contrast to benzene ring of lignocaine. According to some authors, ability of articaine to diffuse into the bone can produce pulpal anesthesia in mandibular teeth even after infiltration anesthesia.\[[@ref15]\] Clinical studies comparing the success rate of 4% articaine with that of 2% lignocaine have shown that 4% articaine was superior to 2% lignocaine as a general-purpose anesthetic.\[[@ref16]\]

Aim of the study {#sec2-1}
----------------

The purpose of the study was to evaluate the anesthetic efficacy of X-tip intraosseous injection in patients with symptomatic irreversible pulpitis in mandibular posterior teeth, using 4% articaine with 1:100,000 adrenaline as local anesthetic when the conventional inferior alveolar nerve block proved ineffective.

MATERIALS AND METHODS {#sec1-2}
=====================

Thirty patients, 15 males and 15 females 15-53 years of age with a diagnosis of symptomatic irreversible pulpitis of mandibular posterior teeth were included in this study. Approval for the study was obtained from institutional ethical committee and written informed consent was acquired from each patient.

The diagnosis of irreversible pulpitis was confirmed by a chief complaint of spontaneous pain or pain at night, together with cold test and electric pulp testing showing an elevated and lingering pain response. Vitality of these teeth was first tested with cold pulp tester, dichlorodifluoromethane (Endo-Frost, Roeko, Langenau, Germany) followed by electric pulp tester (Digitest Pulp Tester). In all 30 patients selected, control teeth showed normal response and the inflamed teeth showed an elevated and prolonged pain response to these tests.

Inferior alveolar nerve block injection was administered using 1.7 ml of 4% articaine with 1:100,000 adrenaline (Septanest with adrenaline 1:100,000, Septodont, France) with conventional long buccal injection. Before commencing access preparation, it was ensured that the control teeth did not respond to the maximum output of the electric pulp tester and the cold test. The patients were instructed to rate any discomfort during access using a Heft-Parker visual analogue scale (VAS) \[[Figure 1](#F1){ref-type="fig"}\]. The VAS scale consists of four categories. No pain corresponded to 0 mm. Mild pain was defined as greater than 0 mm and less than or equal to 54 mm. Mild pain included the descriptors of faint, weak, and mild pain. Moderate pain was defined as greater than 54 mm and less than 114 mm. Severe pain was defined as greater than or equal to 114 mm. Severe pain included the descriptors of strong, intense, and maximum possible. Supplemental intraosseous X-tip injection was administered in patients who had moderate or severe pain (VAS rating greater than 54 mm) on access into dentin, when entering the pulp chamber or with initial file insertion.

![Heft-Parker VAS pain scale used for pain assessment](JCD-17-522-g001){#F1}

The intraosseous injection with the X-tip system (Dentsply Maillefer, USA) was administered in the following manner:

The perforation site was selected according to manufacturer\'s instructions, 2-4 mm apical to alveolar crestal bone level in the attached gingiva, at a site distal or mesial to the operating tooth. After determination of the perforation site, the perforator attached in micromotor handpiece was pushed through the attached gingiva until the X-tip contacted bone.

After placing the drill at a 90° angle to the bone, the slow-speed air motor handpiece was activated and drilled at 90° to the bone.\[[@ref17]\] In 2-4 seconds, the drill perforated the cortical bone into the cancellous bone. The handpiece was always activated while the perforator was within the bone to prevent breakage that might occur if the perforator was allowed to stop rotating. After perforation, the drill was withdrawn from the guide sleeve, leaving the guide sleeve in place.

The 27-gauge ultrashort X-tip needle was inserted into the guide sleeve to its hub, and 1.7 ml of 4% articaine with 1:100,000 adrenaline (Septanest with adrenaline 1:100,000, Septodont, France) was delivered over a 1-minute time period.

After administration of anesthetic solution, the guide sleeve was removed using a hemostat. Endodontic access preparation was continued following rubber dam application. The success of the supplemental X-tip technique is defined as the ability to access the pulp chamber, place initial files, and instrument the tooth without pain (VAS score of zero) or mild pain (VAS rating less than or equal to 54 mm).\[[@ref9]\] If the patient had moderate to severe pain (VAS rating greater than 54 mm) during access or initial instrumentation, the X-tip technique was considered as a failure and an intrapulpal injection was administered.

RESULTS {#sec1-3}
=======

Out of the 30 patients who participated in the study, 25 patients experienced no pain or mild pain and were counted as success. Five patients who experienced moderate to severe pain during access or initial instrumentation after intraosseous injections were considered a failure. Anesthetic success and anesthetic failure after intraosseous injection was shown in [Table 1](#T1){ref-type="table"}.

###### 

Anesthetic success and failure after intraosseous injection

![](JCD-17-522-g002)

DISCUSSION {#sec1-4}
==========

The various factors associated with anesthetic failure for conventional IAN block include accessory innervations, accuracy of needle placement, anesthetic solution migration along the path of least resistance, tetrodotoxin-resistant class of sodium channels, which have been shown to be resistant to the action of local anesthetics, anxiety, psychological factors, and altered resting potentials and decreased excitability thresholds of nerves arising from inflamed tissue.\[[@ref8]\] Owing to these myriad limiting factors, supplemental injections become necessary in cases when inferior alveolar nerve block is not effective in providing satisfactory anesthesia. In needle-phobic patients, fear associated with dental injections can be managed by using pressure anesthesia. Needleless jet injection helps in achieving adequate anesthesia with significantly less fear and pain. The time of onset of action for pressure anesthesia was less when compared to classic needle infiltration but the total duration of anesthesia was more for needle infiltration anesthesia. It can be used for restorative procedures of short duration and direct pulp injections.\[[@ref10]\]

In this study, the anesthetic success using X-tip intraosseous injection was 83.33%. The results of this study shows that supplemental X-tip intraosseous injection helps in achieving successful pulpal anesthesia in patients with symptomatic irreversible pulpitis. None of the X-tip perforators broke, and the onset of anesthesia was immediate. The thickness of the cortical plate of posterior mandibular region condemns the use of infiltration injections. The intraosseous injection overcomes this problem by allowing direct access to the cancellous bone via perforation of the cortical bone.

In this study, 4% articaine with 1:100,000 adrenaline was preferred over 2% lignocaine with 1:100,000 epinephrine. The thiophene portion of the molecule gives articaine high lipid solubility. This fact is critical, as higher the lipid solubility, the higher is the potency and better will be the diffusion through the medium into which it is injected, and therefore, the greater is its ability to cross the lipid membranes of the epineuria.\[[@ref18]\]

A significant molecular difference exists between articaine and the other amides. Articaine possesses an additional ester linkage on the thiophene ring. This molecular configuration is subject to rapid hydrolysis by plasma cholinesterases after it is absorbed into the systemic circulation. Almost 95% of the drug is broken down this way into inactive metabolites. Only the remaining 5-10% is subject to the slower, traditional hepatic metabolism. Allergic reactions are extremely rare with amides, including articaine. The allergen paraminobenzoic acid (PABA), a frequent metabolite of ester metabolism, is not a by-product of the hydrolysis phase of articaine.\[[@ref18]\]

CONCLUSION {#sec1-5}
==========

Within the limitations of this study, we can conclude that when the inferior alveolar nerve block fails to provide profound pulpal anesthesia, the X-tip system using 4% articaine, was successful in achieving pulpal anesthesia in mandibular posterior teeth of patients presenting with irreversible pulpitis. Supplemental intraosseous injection with X-tip using 4% articaine with 1:100,000 adrenaline enabled soothing, swift, and sound anesthesia.
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